Seven West emerges as key investor for NWZ

Published 20-APR-2016 13:26 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Seven West Media (ASX:SWM) has jumped on board with Newzulu (ASX:NWZ) by taking part in a $5 million placement to strategic and cornerstone investors.

NWZ revealed the planned deal today, with SWM keen to get on board with the ‘crowdsourcing’ player – opening up the possibility of SWM working with NWZ on “crowd sourced content initiatives”.

The placement will be for 500 million shares at 1c each, while investors will also get the opportunity to take part in the 1c offer with a separate fully underwritten $2 million entitlement issue to be made available.

The placement also confirms Thorney Investment Group as a cornerstone investors, while SWM and Thorney will gain 90 million options, 72 million at 2c with a 3 year expiry date and 18 million at 3c with a 3 year expiry date.

The appearance of an established big media name on the register, not just via a partnership, will be somewhat of a boon for NWZ – which has recently focused on the North American market but in the past has focused on content initiatives with players such as the ABC.

“Newzulu is delighted to have completed this fundraising with the support of Australia’s leading media company in Seven West Media and a further investment from financial cornerstone Thorney,” NWZ managing director Alexander Hartman said.

“Further, Newzulu is now in the exciting position to collaborate with Seven West on world leading crowd sourced content initiatives across Seven’s digital and traditional publishing and broadcast assets.”

About NWZ

Newzulu is a news platform where publishers can connect with citizen journalists who are on the scene of unfolding news taking footage with their mobile phones.

In the past, citizen journalists had to connect with individual newsroom, and then wait for a response.

For publishers, they had to verify the content was real.

NWZ however takes a lot of the gruntwork out of the process and makes things easier for both publisher and citizen journalist.

Citizen journalists simply log onto the Newzulu platform, upload the footage and then wait for the cash to roll in.

Newzulu verifies the content to make sure it’s legitimate, and then pays the citizen journalist a fee for the content.

Then a Newzulu partner such as Agence France Presse or Getty Images then onsells the footage to news organisations which have paid for access to the Newzulu library.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free